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Purpose: to investigate the occurrence of intra-operative device-related complications during stent-grafting for abdominal
aortic aneurysm.
Materials and Methods: data on patient characteristics, vascular morphology, operative technical details, procedural
and device-related complications were obtained from the European collaborators on stent-graft techniques for abdominal
aortic aneurysm repair (EUROSTAR) registry. Only intra-operative device-related complications were taken into account.
Potential risk factors for device-related complications were examined by logistic regression analysis. The association
between these complications and conversion to open surgery and death were determined.
Results: between January 1994 and July 2000, 2862 patients in 90 participating hospitals underwent endovascular
abdominal aortic aneurysm repair. Device-related complications occurred in 238 (8.3%) patients. Complications were
associated with the age of the patient (p=0.002), gender (p=0.05), smoking habit (p=0.001), pre-operative aneurysm
diameter (p=0.005), type of device implanted (p=0.0001), fitness of the patient for open surgery (p=0.002), and year
of operation (p=0.001). Adjusted for risk factors, the occurrence of complications decreased between 1994 to 2000 from
21.7% to 7.3%, respectively. Patients with device-related complications were 13.6 times (95% CI; 9.2–20.1) more likely
to have conversion to an open procedure and 2.4 times (95% CI; 1.4–4.0) more likely to die within 30 days of the
operation.
Conclusions: intra-operative device-related complications were common, although appear to be decreasing in frequency,
and were significantly related to conversion and post-operative death.
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Introduction study was conducted. Potential risk factors were ex-
amined to identify which features contributed to the
Endovascular treatment of abdominal aortic aneurysm occurrence of intra-operative device-related com-
plications. In addition the consequence of device-re-is a technically demanding procedure.1–3 Com-
plications associated with this technique include mor- lated complications were studied.
tality, procedure failure, device-related complications
as well as systemic, arterial or cardiac complications
and renal failure.4,5
MethodsRelatively little is known about risk factors for intra-
operative complications due to the device itself or its
Patientsdelivery system.6–8 Furthermore, the technique has
evolved with the introduction of commercially manu-
This study was part of the European collaborators onfactured and modular devices, rendering the first re-
stent-graft techniques for abdominal aortic aneurysmported outcomes outdated. To investigate the incidence
repair (EUROSTAR) study, a voluntary registry de-of intra-operative device complications due to the
signed to investigate the health risks in patients treateddevice itself or its delivery system over time, a cohort
by endovascular techniques.9 The cohort consists of
consecutive patients treated endovascular in a large
number of European vascular institutions col-
∗ Please address all correspondence to: R. J. F. Laheij, UMC St laborating in the EUROSTAR registry. The patientsRadboud, Department of Medical Technology Assessment, PO Box
9101, 6500 HB Nijmegen, The Netherlands. received information about this registry and consented
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Table 1. Patients’ characteristics.to have their data included in the study. The majority
of the patients (84%) were included prospectively Device-related complications
using pre-treatment registration.
Characteristics No Yes
Age (years)∗ 70.4 (7.8) 72.0 (7.9)
Gender†
Male 2425 (92%) 211 (8%)Study variables
Female 195 (88%) 27 (12%)
Smoking†
The study variables included demographic and clinical Not for the last 10 years 1058 (91%) 99 (9%)
No, smoked in the last 10 687 (91%) 69 (9%)characteristics of the patients. Initial examination in-
yearscluded a medical history, physical examination, con- Current, less than 1 pack/ 435 (94%) 27 (6%)
trast enhanced computed tomography and day
Current, more than 1 pack/ 206 (85%) 37 (15%)angiography to assess vascular morphology. The op-
dayerative data included, type of stent-graft used and the Aortic neck diameter (mm)∗ 22.7 (2.9) 22.7 (3.1)
occurrence of intra-operative device-related com- Aneurysm diameter (mm)∗ 55.9 (11.0) 59.0 (11.4)
Aortic neck length (mm)∗ 27.3 (11.5) 28.6 (12.0)plications as reported by the operator. In the case
Angulation present†record form the intra-operative device-related com- Aortic neck 528 (89%) 66 (11%)
plications were categorised as specific data entry end- Aneurysm 277 (91%) 28 (9%)
Right iliac artery 836 (89%) 98 (11%)points: inability to advance the delivery sheath,
Left iliac artery 974 (90%) 104 (10%)inability to deploy the device, unresolved device oc- Device configuration†
clusion, unresolved one limb occlusion, unresolved Bifurcated 2438 (92%) 212 (8%)
Straight 108 (91%) 11 (9%)device stenosis, unresolved one limb stenosis, device
Aorta-uni-iliac 78 (84%) 15 (16%)migration and other device-related problems, for ex- Type of device used†
ample balloon bursting. Follow-up consisted of clinical AneuRx 680 (96%) 27 (4%)
EVT/Ancure 96 (76%) 31 (24%)visits at 1, 3, 6, 12 and 18 months after operation
Excluder 128 (93%) 9 (7%)and at yearly intervals thereafter. Outcome events of Stentor 290 (93%) 20 (7%)
interest were early conversion to open procedure and Talent 351 (92%) 32 (8%)
Vanguard 800 (90%) 92 (10%)operative death, both defined as occurring within 30
Zenith 223 (93%) 16 (7%)days of operation. Additionally, all conversions and Other 47 (84%) 9 (16%)
deaths were studied.
∗Mean (standard deviation); † frequency (percentage).
Missing values are account for differences between tables/text.
entry point in the case record form, is a measure forData analysis
the overall general medical condition of patients as
determined by the physician at the different centres.To quantify the correlation between device-related
The number of consecutive procedures performed incomplications and major outcome events, relative risks
a hospital was regarded as an indicator for specialist-with 95% confidential intervals and for duration of
team experience. The population was divided intofollow-up adjusted hazard risks were calculated. A
quartiles, using the 25th, 50th and 75th percentilesmultivariate logistic regression model was constructed
as cut-off points of consecutive procedures to defineby selecting variables found to be associated (p<0.1)
experience level for uni- and multivariate analyses.with complications in the univariate analysis. The
All statistical analyses were performed using SASpotential risk factors we assessed were: age; gender;
software (SAS version 6.12, SAS Institute Inc.).tobacco smoking; aortic neck diameter, length and
angulation; aneurysm diameter and angulation; right
and left iliac artery angulation; distal neck diameter
<20 mm; presence of iliac aneurysm; fitness of the Results
patient for open surgery; number of procedures per-
formed in a hospital; calendar period; type and con- We studied 2862 patients from 90 participating hos-
pitals that underwent endovascular abdominal aorticfiguration of device; presence of a radiologist at
operation; and whether the data was collected retro- aneurysm repair between January 1994 and April 2000.
In 238 (8.3%) of these patients one or more intra-spectively or prospectively. Angulation was defined
as presence of significant angulation (>60 degrees). operative device-related complications occurred (Table
1). Patients with complications were older, more oftenFitness of the patient for open surgery, a specific data
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Table 2. Univariate and multivariate analyses.
Univariate analysis Multivariate analysis
Variables Odds ratio (95% CI) p-value Odds ratio (95% CI) p-value
Age (years) 1.03 (1.01–1.05) 0.002 1.03 (1.01–1.05) 0.002
Male gender 0.63 (0.41–0.96) 0.04 0.62 (0.39–0.98) 0.05
Smoking
No: not for the last 10 years 1.0 0.001 1.0 0.001
No: smoked in the last 10 years 1.07 (0.78–1.48) 1.03 (0.73–1.46)
Current: less than 1 pack/day 0.66 (0.43–1.03) 0.69 (0.43–1.11)
Current: more than 1 pack/day 1.92 (1.28–2.88) 1.86 (1.18–2.94)
Aortic neck diameter (mm) 0.99 (0.95–1.04) 0.74
Aneurysm diameter (mm) 1.02 (1.01–1.03) 0.0001 1.02 (1.01–1.03) 0.005
Aortic neck length (mm) 1.01 (1.00–1.02) 0.13
Angulation present
Aortic neck 1.52 (1.13–2.05) 0.01 NS
Aneurysm 1.13 (0.75–1.71) 0.57
Right iliac artery 1.50 (1.13–1.96) 0.004 NS
Left iliac artery 1.31 (1.00–1.72) 0.05 NS
Type of device used
AneuRx 0.35 (0.22–0.54) 0.0001 0.52 (0.32–0.85) 0.0001
EVT/Ancure 2.81 (1.77–4.44) 3.12 (1.87–5.21)
Excluder 0.61 (0.30–1.24) 0.97 (0.45–2.10)
Stentor 0.60 (0.36–1.00) 1.41 (0.63–3.17)
Talent 0.79 (0.52–1.21) 1.16 (0.72–1.85)
Vanguard 1.0 1.0
Zenith 0.62 (0.36–1.08) 0.99 (0.51–1.92)
Other 1.71 (0.86–3.38) 3.20 (1.53–6.72)
Device configuration
Bifurcated 0.45 (0.26–0.80) 0.04 NS
Straight 0.53 (0.23–1.22)
Aorta-uni-iliac 1.0
Patients reported unfit for surgery 2.11 (1.51–2.94) 0.0001 1.82 (1.26–2.62) 0.002
Distal neck <20 mm 1.26 (0.72–2.23) 0.43
Iliac aneurysm present 0.23 (0.06–0.95) 0.01 NS
Radiologist present at operation
Radiologist only 1.02 (0.13–7.98) 0.56
Radiologist and surgeon 1.17 (0.87–1.58)
Surgeon only 1.0
Specialist-team experience
Patient 0–10 per hospital 1.0 0.0001 NS
Patient 11–32 per hospital 1.49 (1.04–2.16)
Patient 33–78 per hospital 1.22 (0.84–1.77)
Patient >78 per hospital 0.59 (0.39–0.90)
Retrospectively included 1.22 (0.87–1.72) 0.26
Year of operation
1994 1.0 0.0001 1.0 0.0005
1995 0.30 (0.06–1.41) 0.37 (0.06–2.36)
1996 1.47 (0.42–5.09) 2.14 (0.52–8.81)
1997 1.49 (0.44–4.99) 1.82 (0.46–7.29)
1998 0.89 (0.26–2.98) 1.16 (0.29–4.64)
1999 0.70 (0.21–2.38) 0.88 (0.22–3.57)
2000 0.54 (0.14–2.01) 0.64 (0.14–2.89)
of female gender, smoked more often more than 1 smoking habit (p=0.001), aneurysm diameter (p=
0.005), type of device (p=0.0001), patients reportedpackage per day, had larger aneurysm diameters, aortic
neck and iliac arteries were more often significantly unfit for open repair (p=0.002), and the calendar
period (p=0.001) were found to be independentlyangulated, iliac aneurysms were more often present
and were more often reported unfit for open procedure associated with intra-operative device-related com-
plications. The occurrence of complications was notthan those patients without complications (Table 2).
Furthermore, the type of device, calendar period and consistent over the study period (Fig. 1). The adjusted
risk for device-related complications decreased fromspecialist-team experience were significantly different
between patients with and without complications. 21.7% in 1994 to 7.3% in 2000. This did not change when
an additional correction for specialist-team experienceAfter adjusting for the significant features found in
the univariate analysis, age of the patient (p=0.002), was made (Fig. 2).
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Fig. 1. Adjusted time trend of occurrence of intra-operative device-related complications (95% CI) during endovascular repair.
Fig. 2. Adjusted risk for intra-operative device-related complications (95% CI) by the number of procedures performed.
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Table 3. Relative risk of early conversion and operative mortality after device-related complications.
Early conversion Operative mortality
Complications n (%) n (%) Relative risk (95% CI) n (%) Relative risk (95% CI)
Device-related complications 238 (8.3) 32 (13.5) 13.6 (9.2–20.1) 15 (6.3) 2.4 (1.4–4.0)
Inability to advance delivery sheath 65 (2.3) 13 (20.0) 12.4 (7.7–20.0) 7 (10.8) 3.9 (1.9–7.8)
Inability to deploy device 39 (1.4) 5 (12.8) 6.8 (3.1–14.9) 1 (2.6) 0.9 (0.1–6.0)
Device occlusion (unresolved) 4 (0.1) 2 (50.0) 25.5 (10.0–64.8) 2 (50.0) 17.2 (6.3–47.1)
One device limb occluded (unresolved) 5 (0.2) 1 (20.0) 10.1 (2.1–48.8) 0 (0)
Device stenosis (unresolved) 5 (0.2) 1 (20.0) 10.1 (2.1–48.8) 0 (0)
One device limb stenotic (unresolved) 5 (0.2) 1 (20.0) 10.1 (2.1–48.8) 0 (0)
Device migration 39 (1.4) 9 (23.1) 13.3 (7.7–22.8) 3 (7.7) 2.6 (0.9–7.9)
Balloon bursting 26 (0.9) 0 (0) 0 (0)
Other 85 (3.0) 10 (11.8) 6.8 (3.8–12.2) 7 (8.2) 2.2 (1.1–4.7)
Table 4. Number of patients (%) with complications per device. The total numbers might not add up to the total number due to
missings.
Complications (no. of patients (%))
Inability to advance Inability to deploy Perioperative
n delivery sheath device Device migration (<30 days) death
AneuRx 707 2 (0.3) 4 (0.6) 9 (1.3) 16 (2.3)
EVT/Ancure 127 13 (10.2) 4 (3.2) 1 (0.8) 3 (2.4)
Excluder 137 3 (2.2) 0 (0) 4 (2.9) 3 (2.2)
Stentor 310 5 (1.6) 6 (1.9) 3 (1.0) 15 (4.8)
Talent 383 6 (1.6) 4 (1.0) 2 (0.5) 15 (3.9)
Vanguard 892 27 (3.0) 18 (2.0) 13 (1.5) 22 (2.5)
Zenith 239 6 (2.5) 2 (0.8) 1 (0.4) 6 (2.4)
Other 56 2 (3.6) 0 (0) 6 (10.7) 5 (8.9)
In total 64 (2.2) 38 (1.3) 39 (1.4) 85 (3.0)
Table 5. Adjusted Hazard Risk of conversion and death afterInability to advance the delivery sheath occurred
device-related complications.most often (Table 3). Other device-related com-
Hazard R (95% CI)plications consisted mainly because of arterial damage
or perforation (n=34), sheath or delivery system rup-
Complications n (%) Conversion Deathture (n=8), twisting of device or device limbs (n=
Device-related 238 (8.3) 6.8 (4.6–10.0) 1.6 (1.1–2.4)9) and guide wire kinking or twisting (n=6). Intra-
complicationsoperative device-related complications were most fre-
Inability to advance 65 (2.3) 6.9 (3.9–12.1) 1.7 (0.9–3.3)quently observed with the EVT/Ancure stent-graft delivery sheath
Inability to deploy 39 (1.4) 4.8 (2.2–10.4) 0.5 (0.1–2.2)(Table 4). Conversion to open surgery was necessary
devicein 58 patients within 30 days of the operation and in
Device occlusion 4 (0.1) 14.5 (3.6–59.0) 7.7 (1.9–31.0)50 patients during follow-up. Eighty-five out of a total (unresolved)
One device limb 5 (0.2) 6.4 (0.9–46.3) –of 257 deaths occurred within 30 days of the operation
occluded (unresolved)(Table 4). Intra-operative device-related complications
Device stenosis 5 (0.2) 9.9 (1.4–71.2) –were associated with conversion to open surgical re- (unresolved)
One device limb stenotic 5 (0.2) 12.3 (3.0–50.1) –pair. Patients who have had a complication were 13.6
(unresolved)times (95% CI; 9.2–20.1) more likely to have an early
Device migration 39 (1.4) 10.8 (5.6–20.9) 2.0 (0.7–5.4)conversion than patients without a device-related com- Balloon bursting 26 (0.9) – 2.2 (1.0–5.0)
Other 85 (3.0) 4.3 (2.3–7.8) 2.2 (1.3–3.8)plication. In all measured subcategories an increased
risk on early conversion was found. When all 108
conversions were regarded, this risk was 6.8 (95% CI;
4.6–10.0) and was increased in all subcategories, except early conversions device-related complications were
reported, whereas this was 7% in patients withoutfor one device limb occlusion (Table 5). In 36% (39/
108) of the conversions and even in 55% (32/58) of the conversion.
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The patients with device-related complications were regarded as specialist-team experience. Since op-
erations are generally performed in teams, this is2.4 times (95% CI; 1.4–4.0) more likely to die within
30 days of the operation (Table 3). Six of the 15 only an approximation of operator experience. In the
univariate analyses a relation between device-relatedintra-operative deaths were secondary to the need for
conversion, resulting in an operative mortality risk complications and experience was found, though after
correcting for other variables device-related com-directly related to the presence of intra-operative de-
vice-related complications of 1.7 (95% CI; 0.9–3.4). plications were not associated with specialist-team
experience. However, device-related complications arePatients with unresolved device occlusion were 17.2
times more likely to die within 30 days of the operation still decreasing over time, even after correction for risk
factors associated with the indications of case selectionthan patients without this complication (p=0.001).
This operative mortality risk was even higher when (vascular morphology) and specialist-team experience.
The technique of stent-grafting is continually ad-death without a prior conversion was regarded (hazard
risk=18.9; p=0.001). When all deaths were regarded vancing. Refinements of the stent-framework and its
cover and better delivery sheaths with smaller externalno significantly increased death risk was found
(Table 5). diameters are becoming available. Because endo-
vascular abdominal aortic aneurysm repair seems to
have obvious advantages over open surgical inter-
vention it has and will continue to be developed
Discussion and refined. At present, the first national organised
randomised clinical trials to compare endovascular
These data suggest that the technology is improving, versus open surgical repair have started in the United
resulting in fewer device-related complications. Al- Kingdom (EVAR-trial), France and the Netherlands
though stent-grafts are available in a variety of con- (DREAM-trial). Timing of studies is important. There
figurations this was not independently associated with is a window of opportunity during which a study is
the occurrence of device-related complications. more likely to have an impact on clinical practice.11 In
A major strength of our analysis was the large other words, if a therapeutic technique is changing
number of patients and type of stent-grafts involved. constantly, a poorly timed formal randomised con-
Cohort studies are useful for evaluating the range trolled trial may be unhelpful and could slow the
of complications related to endovascular abdominal developmental process. There has been a continually
aortic repair. It should be noted that approximately improving technology of stent-graft design and de-
16% of the data were collected retrospectively, pre- livery from 1994 to 2000. It is our opinion that devices
dominantly the early years.6 A concern in collecting and techniques should be developed further before
data retrospectively is the possibility of bias.10 The embarking on randomised controlled trials comparing
frequency of intra-operative device-related com- outcomes of endovascular versus open surgical inter-
plications might have been underreported in the retro- vention.
spectively collected data, though no statistical The age of the patients has been positively correlated
difference in these complications was found between with the occurrence of device-related complications.
the retro- and prospectively collected data in the uni- Ageing decreases the compliance of both the muscular
and multivariate analyses. Besides, if there was an and elastic components of the arterial circulation.12
underestimation of these complications in the retro- Aortic wall distensibility decreases with age, which
spective data the time trend found in this study would might be the reason for the increased occurrence of
be even more distinct. device-related complications in older patients.
The intra-operative device-related complications as The majority of patients with abdominal aortic an-
reported in the EUROSTAR registry might be in- eurysms treated in the current study met the currently
fluenced by several factors. The decrease in device- recognised criteria for open surgical intervention.
related complications over time may be due to a However, in the early development of a new technique,
combination of improvements in the devices and the especially high-risk patients will be treated.3,13,14 The
delivery system, changing indications for case selection health status of patients in our study was reported as
as well as to the improved technical competency of in fitness of the patient for open surgery as judged by
the operators. Only a slight decrease in complications the operator. Here, we evaluated 351 patients judged
was observed with increasing number of procedures unfit for open surgery. A statistical association between
performed by a specialist team. Assuming that the high-risk patients and device-related complications
experience increases over time, the number of con- was found. However, the time trend of complications
is still observed after correction for high-risk patients.secutive procedures performed per hospital might be
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